Avoidable portion of tobacco-attributable acute care hospital days and its cost due to implementation of different intervention strategies in Canada

International Journal of Environmental Research and Public Health

Volumn 6, Issue 8, 2009, Pages 2179-2192

  Popova, Svetlana ^a,b   Patra, Jayadeep ^a   Rehm, Jürgen ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cardiovascular disease; Health effects; Lung cancer; Public health; Smoking cessation; Tobacco consumption reduction; Tobacco smoking; Tobacco taxation

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CANADA; CIGARETTE SMOKING; COST CONTROL; COUNSELING; HOSPITAL COST; HUMAN; MORBIDITY; NICOTINE REPLACEMENT THERAPY; PREVALENCE; SMOKING CESSATION; SYSTEMATIC REVIEW;

NICOTIANA TABACUM;

ADULT; AGED; CANADA; COST OF ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PUBLIC POLICY; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 69449106271     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6082179     Document Type: Article

References (33)

1. USDHHS - US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General; USDHHS, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health: Atlanta, GA, USA, 2004.
2. WHO. The World Health Report 2002: Reducing Risks, Promoting Healthy Life; WHO: Geneva, Switzerland, 2002.
3. Rehm, J.; Baliunas, D.; Brochu, S.; Fischer, B.; Gnam, W.; Patra, J.; Popova, S.; Sarnocinska-Hart, A.; Taylor, B. The Costs of Substance Abuse in Canada 2002; Canadian Centre on Substance Abuse: Ottawa, Canada, 2006.
4. Rehm, J.; Gnam, W.; Popova, S.; Baliunas, D.; Brochu, S.; Fischer, B.; Patra, J.; Sarnocinska-Hart, A.; Taylor, B. The social costs of alcohol, illegal drugs and tobacco in Canada 2002. J. Stud. Alcohol Drugs 2007, 68, 886-895. (Pubitemid 350144498)
5. Drummond, M.; O'Brien, B.; Stoddart, G.L.; Torrance, G.W. Methods for the Economic Evaluation of Health Care Programmes; Oxford University Press: Oxford, UK, 1997.
6. Drummond, M.; McGuire, A. Economic Evaluation in Health Care: Merging Theory with Practice; Oxford University Press: Oxford, UK, 2001.
7. Rehm, J. Ökonomische Aspekte von Substanzmissbrauch. In Lehrbuch der Suchterkrankungen; Gastpar, M., Mann, K., Rommelspacher, H., Eds.; G. Thieme Verlag: Stuttgart, Germany, 1999; pp. 118-127.
8. Rehm, J.; Frick, U.; Fischer, B. Zur Ökonomie des Suchtmittelgebrauchs. In Oekonomie der Sucht und Suchttherapie; Tretter, F., Erbas, B., Sonntag, G., Eds.; Pabst: Lengerich, Berlin, Germany, 2004; pp. 233-244.
9. Tretter, F.; Erbas, B.; Sonntag, G. Okonomie der Sucht und Suchtterapie; Pabst: Lengerich, Berlin, Germany, 2004.
10. Ezzati, M.; Lopez, A.D.; Rodgers, A.D.; Vander Hoorn, S.; Murray, C.J.L.; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of Ddisease. Lancet 2002, 360, 1347-1360.
11. Ezzati, M.; Vander Hoorn, S.; Rodgers, A.; Lopez, A.; Mathers, C. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003, 362, 271-280. (Pubitemid 36936837)
12. Shibuya, K.; Ciecierski, C.; Guindon, E.; Bettcher, D.; Evans, D.; Murray, C. WHO framework convention on tobacco control: development of an evidence based global public health treaty. BMJ 2003, 327, 154-157. (Pubitemid 36876212)
13. Single, E.; Robson, L.; Xie, X.; Rehm, J. The costs of substance abuse in Canada; Canadian Centre on Substance Abuse: Ottawa, Canada, 1996.
14. Single, E.; Robson, L.; Xie, X.; Rehm, J. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction 1998, 93, 991-1006.
15. Murray, C.; Lopez, A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Harvard University: Cambridge, MA, USA, 1996.
16. Murray, C.; Evans, D.; Archarya, A.; Blatussen, R. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 2000, 9, 235-251.
17. WHO. World Health Report 2001: Mental Health: New Understanding, New Hope; WHO: Geneva, Switzerland, 2001.
18. Miettinen, O. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am. J. Epidemiol. 1974, 99, 325-332.
19. Eide, G.; Heuch, I. Attributable fractions: fundamental concepts and their visualization. Stat. Methods Med. Res. 2001, 10, 159-193. (Pubitemid 32586160)
20. Walter, S.D. The estimation and interpretation of attributable risk in health research. Biometrics 1976, 32, 829-849.
21. Walter, S.D. Prevention of multifactorial disease. Am. J. Epidemiol. 1980, 112, 409-416.
22. Rothman, K. Causes. Am. J. Epidemiol. 1976, 104, 587-592.
23. Rothman, K.; Greenland S. Causation and Casual Inference, 2nd ed.; Lippincott-Raven Publishers: Philadelphia, PA, USA, 1998.
24. IARC - International Agency for Research on Cancer. Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking; IARC: Lyon, France, 2004.
25. English, D.; Holman, C.; Milne, E.; Winter, M.; Hulse, G.; Codde, G.; Bower, G.; Corti, B.; de Klerk, N.; Knuiman, M.; Kurinczuk, J.; Lewin, G.; Ryan, G. The quantification of drug caused morbidity and mortality in Australia 1995; Commonwealth Department of Human Services and Health: Canberra, Australia, 1995.
26. Statistics Canada. Canadian Community Health Survey, cycle 2.1; Statistics Canada: Ottawa, Cannada, 2003.
27. Rehm, J.; Zahringer, S.; Egli, S. The Epidemiologic and Economic Evaluation of Different Forms of Tobacco Prevention for Switzerland: an Analysis of Exemplary Interventions using Secondary Data; Insitut fur Suchtforschung (ISF): Zurich, Switzerland, 2004.
28. CIHI-Canadian Institute for Health Information. Data Quality Documentation: Discharge Abstract Database 2002-2003; CIHI: Ottawa, ON, Canada, 2004.
29. CIHI-Canadian Institute for Health Information. Canadian MIS Database: Hospital Finance Performance Indicators 1999-2000 to 2001-2002; CIHI: Ottawa, ON, Canada, 2004.
30. Ranson, K.; Jha, P.; Chaloupka, F.; Nguyen, S. The effectiveness and cost-effectiveness of price increases and other tobacco-control policies. In Tobacco Control in Developing Countries; Jha, P., Chaloupka, F., Eds.; Oxford University Press: New York, NY, USA, 2000; pp. 427-447.
31. Lancaster, T.; Stead, L.F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. 2006, 4, DOI: 10.1002/14651858. CD001292.pub2.
32. Silagy, C.; Lancaster, T.; Stead, L.; Mant, D.; Fowler, G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2004, 3, DOI: 10.1002/ 14651858.CD000146.pub3.
33. Lancaster, T.; Stead, L. Physician advice for smoking cessation. Cochrane Database Syst. Rev. 2004, 4, DOI: 10.1002/14651858.CD000165.pub3.